BARTONELLA IGM

The BARTONELLA IGM test is a serological assay performed on a blood sample to detect IgM-class antibodies against Bartonella species, indicating recent or acute infection. Samples collected at home by a trained phlebotomist are processed in accredited Dubai laboratories using validated immunoassay methods to ensure reliable results and timely reporting.

This test is important for early identification of Bartonella-related illnesses such as cat‑scratch disease, bacillary angiomatosis in immunocompromised patients, and cases of unexplained fever or culture‑negative endocarditis where recent exposure is suspected. Results support clinician decision‑making for prompt treatment and further diagnostic workup and are delivered securely to patients and their healthcare providers within the UAE healthcare framework.

• Bartonella IgM antibodies (total)
• Bartonella henselae IgM
• Bartonella quintana IgM
• Antibody titre (qualitative/quantitative where applicable)

• Recent cat scratch or bite with local lymphadenopathy
• Unexplained fever or prolonged febrile illness
• Suspicion of culture‑negative endocarditis
• Immunocompromised patients with vascular or skin lesions
• History of tick/flea exposure with systemic symptoms

• Rapid detection of recent Bartonella infection via IgM serology
• Convenient at‑home blood collection by certified phlebotomists
• Analysis performed by accredited Dubai laboratories for quality assurance
• Timely electronic delivery of results to patients and clinicians in the UAE
• Supports early clinical decision‑making and targeted treatment planning

• At‑home venous blood collection by a trained phlebotomist (serum sample)
• No fasting required prior to sample collection
• Provide recent clinical history, including animal exposures and current antibiotics